Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Astorg

Tim Perryman

OPEN Health Appoints Tim Perryman as Global Head of Operations to Strengthen Operational Excellence and Support Global Growth

OPEN Health today announced the appointment of Tim Perryman as Global Head of Operations, strengthening the company’s operational leadership as it continues to scale its global capabilities and support clients...

OPEN Health

Peter Black

OPEN Health Appoints Peter Black as EVP, Global Client Partner and Transformation Lead to Accelerate Global Client Partnerships and Digital Innovation

OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.

OPEN Health

Cara Priest

OPEN Health Appoints Cara Priest as Chief People Officer to Strengthen Culture, Capability and Organisational Performance

OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and scientific excellence.

OPEN Health

- PMLiVE

OPEN Health appoints Diala Habib as president of two of its practices

Habib will be president of Promotional Medical Education and Patient Engagement

- PMLiVE

Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions

New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...

BOLDSCIENCE

- PMLiVE

Uniphar On Track to Achieve SBTi Target of Halving Scope 1 and 2 Emissions by 2030

[Dublin, 9th October 2025] Uniphar, a global leader in pharmaceutical and medtech solutions, is making progress towards its near-term Science Based Targets initiative (SBTi) goal of halving Scope 1 and...

Uniphar

Streamlining European expansion for cell and gene therapies

Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...

Uniphar

- PMLiVE

Current CGT landscape and future outlook  

What makes CGT unique  Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized to the patient, CGT’s offer...

Uniphar

- PMLiVE

Building for Success: Aligning Preclinical and Phase 1 Strategy with Commercial Goals 

This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term viability. The first article explored the unique scientific and logistical challenges of...

Uniphar

- PMLiVE

Navigating the complexities of launch preparation for Cell and Gene Therapy

Cell and gene therapies (CGT) provide transformative treatment that can treat conditions that were previously considered untreatable. As described in the previous article in this series, most CGTs target patients...

Uniphar

- PMLiVE

Zack Lentz appointed as Chief Commercial Officer at OPEN Health

Lentz’ previous roles include CGO at Inizio Medical and President & CSO at Vaniam Group

Unlocking the future of Learning

By Potter Li and Aaron Fletcher

Amiculum

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links